Literature DB >> 16157256

Response rates in a case-control study: effect of disclosure of biologic sample collection in the initial contact letter.

Joanne S Colt1, Sholom Wacholder, Kendra Schwartz, Faith Davis, Barry Graubard, Wong-Ho Chow.   

Abstract

PURPOSE: Participants in epidemiology studies are often asked to complete an interview and to provide biospecimens. In a population-based case-control study of kidney cancer involving an interview and optional biospecimens, we examined whether mentioning the biospecimens in the initial contact letter adversely affects willingness to be interviewed.
METHODS: Eligible cases (n = 434) and controls (n = 775) in Detroit were alternately assigned to receive one of two versions of the contact letter. Both explained that the study involves an interview with 100 dollars compensation plus an optional component with additional compensation; only one disclosed that the optional component involved biospecimens.
RESULTS: There were no meaningful differences between the groups in willingness to be interviewed. However, among 303 cases and 351 controls already interviewed, the proportion providing biospecimens was higher in the fully informed group: for blood, the differences were 10.8 (95% CI, 2.0, 19.5) for cases and 6.7% (95% CI, -1.7, 15.1) for controls. Findings were similar for saliva.
CONCLUSIONS: In a study involving an interview and optional biospecimens, informing people about the samples in the contact letter seems preferable to a non-specific reference to a second study component. Both approaches yielded similar interview participation rates, but biospecimen participation rates were higher among those informed about the samples in the contact letter.

Entities:  

Mesh:

Year:  2005        PMID: 16157256     DOI: 10.1016/j.annepidem.2004.12.002

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  5 in total

1.  Use of nephron-sparing surgery among renal cell carcinoma patients with diabetes and hypertension.

Authors:  Christopher P Filson; Kendra Schwartz; Joanne S Colt; Julie Ruterbusch; W Marston Linehan; Wong-Ho Chow; David C Miller
Journal:  Urol Oncol       Date:  2013-02-16       Impact factor: 3.498

2.  Surgical approach and the use of lymphadenectomy and adrenalectomy among patients undergoing radical nephrectomy for renal cell carcinoma.

Authors:  Christopher P Filson; David C Miller; Joanne S Colt; Julie Ruterbusch; W Marston Linehan; Wong-Ho Chow; Kendra Schwartz
Journal:  Urol Oncol       Date:  2011-03-17       Impact factor: 3.498

3.  Contemporary clinical epidemiology of renal cell carcinoma: insight from a population based case-control study.

Authors:  David C Miller; Julie Ruterbusch; Joanne S Colt; Faith G Davis; W Marston Linehan; Wong-Ho Chow; Kendra Schwartz
Journal:  J Urol       Date:  2010-10-16       Impact factor: 7.450

4.  Predictors of Response Outcomes for Research Recruitment Through a Central Cancer Registry: Evidence From 17 Recruitment Efforts for Population-Based Studies.

Authors:  Morgan M Millar; Anita Y Kinney; Nicola J Camp; Lisa A Cannon-Albright; Mia Hashibe; David F Penson; Anne C Kirchhoff; Deborah W Neklason; Alicia W Gilsenan; Gretchen S Dieck; Antoinette M Stroup; Sandra L Edwards; Carrie Bateman; Marjorie E Carter; Carol Sweeney
Journal:  Am J Epidemiol       Date:  2019-05-01       Impact factor: 4.897

5.  Will Women Diagnosed with Breast Cancer Provide Biological Samples for Research Purposes?

Authors:  Shelley A Harris; Beatrice A Boucher; Michelle Cotterchio
Journal:  PLoS One       Date:  2015-06-10       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.